Medicis Lab-Derived Dermal Filler On Track For Year-End Approval – Exec

Medicis will hire a 30-40 rep sales force for Q-Med's Restylane non-animal stabilized hyaluronic acid (NASHA)-based surgical wrinkle treatment in time for the product's launch, anticipated by 2004